(19)
(11) EP 4 565 327 A1

(12)

(43) Date of publication:
11.06.2025 Bulletin 2025/24

(21) Application number: 23751966.5

(22) Date of filing: 03.08.2023
(51) International Patent Classification (IPC): 
A61P 17/00(2006.01)
 C07K 16/24(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/244; C07K 2317/76; A61K 2039/505; A61P 17/00
(86) International application number:
PCT/EP2023/071573
(87) International publication number:
WO 2024/028448 (08.02.2024 Gazette 2024/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 04.08.2022 EP 22188873

(71) Applicant: Novartis Pharma AG
4056 Basel (CH)

(72) Inventors:
  • VICARI, Alain
    74160 Neydens (FR)
  • CHVATCHKO MISSOTTEN, Yolande
    1232 Confignon (CH)

(74) Representative: Papapetridis, Ioannis 
Novartis Pharma AG Patent Department Lichtstrasse 35
4056 Basel
4056 Basel (CH)

   


(54) IL-15 INHIBITORS USEFUL FOR THE TREATMENT OF ATOPIC DERMATITIS